Rossari Biotech
707.35
-6.45(-0.90%)
Market Cap₹3,916.40 Cr
PE Ratio28.98
IndustryChemicals
Company Performance:
1D-0.90%
1M+2.43%
6M-1.26%
1Y-15.41%
5Y+0.64%
View Company Insightsright
Latest news about Rossari Biotech
Rossari Biotech Reports 11% Revenue Growth to Rs 543.7 Crore in Q1, EBITDA Margins Decline 3 days ago
Rossari Biotech Limited reported an 11% year-on-year revenue growth to Rs 543.70 crore in Q1, driven by Home, Personal Care and Performance Chemicals (HPPC) and Animal Health and Nutrition (AHN) segments. EBITDA increased by 4.6% to Rs 67.90 crore, with a margin of 12.5%. The company faced production disruptions due to capacity expansion activities and challenges in export business. Management expects mid-double-digit growth of 14-15% for the full fiscal year and is setting up an overseas formulation facility in Southeast Asia.
Rossari Biotech Reports Mixed Q1 Results with Higher EBITDA but Lower Margins 8 days ago
Rossari Biotech Reports Q4 EBITDA Growth and Strong FY2023 Results, Announces Capacity Expansion Apr 25, 2025
Rossari Biotech's Subsidiaries Unveil Ambitious Capacity Expansion Plans Apr 25, 2025